论文部分内容阅读
目的:探讨通脉颗粒(辽宁金丹药业有限公司)治疗慢性心力衰竭的临床疗效。方法:将100例气虚(阳虚)血瘀,水饮内停CHF患者随机分为治疗组50例和对照组50例,治疗组在对照组常规治疗基础上加服通脉颗粒,连续治疗六周,比较两组临床症状,中医症候疗效及心功能。结论:在常规西医治疗基础上加服通脉颗粒,可以进一步改善患者临床症状,心功能及生活质量,安全有效且未出现不良反应。
Objective: To investigate the clinical efficacy of Tongmai Granules (Liaoning Jindan Pharmaceutical Co., Ltd.) in the treatment of chronic heart failure. Methods: 100 cases of Qi deficiency (yang) blood stasis, water stop drinking CHF patients were randomly divided into treatment group 50 cases and control group 50 cases, the treatment group in the control group on the basis of conventional treatment plus service Tongmai granules, continuous treatment of six Weeks, the two groups were compared clinical symptoms, TCM symptoms and cardiac function. Conclusion: Adding Tongmai Granules on the basis of routine Western medical treatment can further improve clinical symptoms, cardiac function and quality of life of patients, which is safe and effective and no adverse reactions occur.